Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
AGEN Quote, Financials, Valuation and Earnings
Last price:
$6.72
Seasonality move
:
-10.51%
Day range:
$6.59 - $6.96
52-week range:
$1.38 - $8.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.13x
P/B ratio:
--
Volume:
1.1M
Avg. volume:
1.5M
1-year change:
-62.1%
Market cap:
$184.2M
Revenue:
$103.5M
EPS (TTM):
-$28.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $88.2M | $295.7M | $98M | $156.3M | $103.5M | |
| Revenue Growth (YoY) | -41.24% | 235.34% | -66.85% | 59.47% | -33.81% | |
| Cost of Revenues | $145M | $182.1M | $197.3M | $237.7M | $156M | |
| Gross Profit | -$56.8M | $113.6M | -$99.2M | -$81.4M | -$52.6M | |
| Gross Profit Margin | -64.42% | 38.42% | -101.24% | -52.05% | -50.79% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $59.2M | $76.4M | $81M | $78.7M | $71.9M | |
| Other Inc / (Exp) | -$5.8M | -$233K | $11.4M | $593K | $9.8M | |
| Operating Expenses | $59.2M | $76.4M | $81M | $78.7M | $71.9M | |
| Operating Income | -$116M | $37.2M | -$180.2M | -$160.1M | -$124.4M | |
| Net Interest Expenses | $61.1M | $65.7M | $61.9M | $97.9M | $117.6M | |
| EBT. Incl. Unusual Items | -$182.9M | -$28.7M | -$230.7M | -$257.4M | -$232.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$182.9M | -$28.7M | -$230.7M | -$257.4M | -$232.3M | |
| Minority Interest in Earnings | $2M | $4.8M | $10.6M | $11.7M | $5.1M | |
| Net Income to Common Excl Extra Items | -$180.9M | -$23.9M | -$220.1M | -$245.8M | -$227.2M | |
| Basic EPS (Cont. Ops) | -$21.00 | -$2.20 | -$15.64 | -$13.75 | -$10.59 | |
| Diluted EPS (Cont. Ops) | -$21.00 | -$2.20 | -$15.64 | -$13.75 | -$10.59 | |
| Weighted Average Basic Share | $8.6M | $11.4M | $14.1M | $17.9M | $21.5M | |
| Weighted Average Diluted Share | $8.6M | $11.4M | $14.1M | $17.9M | $21.5M | |
| EBITDA | -$114.6M | $43.8M | -$161.8M | -$145.9M | -$101.3M | |
| EBIT | -$121.8M | $37M | -$168.8M | -$159.5M | -$114.6M | |
| Revenue (Reported) | $88.2M | $295.7M | $98M | $156.3M | $103.5M | |
| Operating Income (Reported) | -$116M | $37.2M | -$180.2M | -$160.1M | -$124.4M | |
| Operating Income (Adjusted) | -$121.8M | $37M | -$168.8M | -$159.5M | -$114.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.7M | $25.9M | $22.9M | $28M | $24.1M | |
| Revenue Growth (YoY) | -22.53% | 121.36% | -11.72% | 22.28% | -14.07% | |
| Cost of Revenues | $37.8M | $43M | $59.4M | $44M | $21.7M | |
| Gross Profit | -$26.1M | -$17M | -$36.5M | -$16M | $2.4M | |
| Gross Profit Margin | -222.4% | -65.7% | -159.42% | -57.23% | 10% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.4M | $19M | $18.2M | $16.9M | $15.7M | |
| Other Inc / (Exp) | $3.9M | $592K | $446K | -$1.1M | -$264K | |
| Operating Expenses | $16.4M | $19M | $18.2M | $16.9M | $15.7M | |
| Operating Income | -$42.4M | -$36M | -$54.7M | -$32.9M | -$13.3M | |
| Net Interest Expenses | $15.9M | $15.2M | $16.6M | $29.5M | $12.8M | |
| EBT. Incl. Unusual Items | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Minority Interest in Earnings | $726K | $2.3M | $2.6M | $1.6M | $1.1M | |
| Net Income to Common Excl Extra Items | -$53.7M | -$48.3M | -$68.3M | -$61.9M | -$25.3M | |
| Basic EPS (Cont. Ops) | -$5.40 | -$3.80 | -$86.20 | -$60.80 | -$20.60 | |
| Diluted EPS (Cont. Ops) | -$5.40 | -$3.80 | -$86.20 | -$60.80 | -$20.60 | |
| Weighted Average Basic Share | $10M | $12.9M | $792.8K | $1M | $1.2M | |
| Weighted Average Diluted Share | $10M | $12.9M | $792.8K | $1M | $1.2M | |
| EBITDA | -$36.8M | -$33.7M | -$51.7M | -$30.6M | -$10.4M | |
| EBIT | -$38.5M | -$35.4M | -$54.3M | -$34M | -$13.6M | |
| Revenue (Reported) | $11.7M | $25.9M | $22.9M | $28M | $24.1M | |
| Operating Income (Reported) | -$42.4M | -$36M | -$54.7M | -$32.9M | -$13.3M | |
| Operating Income (Adjusted) | -$38.5M | -$35.4M | -$54.3M | -$34M | -$13.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $84.8M | $309.9M | $95M | $161.4M | $99.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $146.4M | $187.3M | $213.7M | $222.3M | $133.6M | |
| Gross Profit | -$61.6M | $122.6M | -$118.7M | -$60.9M | -$34.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $65M | $79M | $80.3M | $77.4M | $70.7M | |
| Other Inc / (Exp) | -$2.5M | -$3.5M | $11.3M | -$959K | $10.6M | |
| Operating Expenses | $65M | $79M | $80.3M | $77.4M | $70.7M | |
| Operating Income | -$126.6M | $43.6M | -$199M | -$138.2M | -$104.9M | |
| Net Interest Expenses | $62.9M | $65M | $63.3M | $110.8M | $101M | |
| EBT. Incl. Unusual Items | -$192M | -$24.9M | -$250.9M | -$250M | -$195.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$192M | -$24.9M | -$250.9M | -$250M | -$195.2M | |
| Minority Interest in Earnings | $2.1M | $9.2M | $10.9M | $10.6M | $4.6M | |
| Net Income to Common Excl Extra Items | -$189.9M | -$15.7M | -$240M | -$239.4M | -$190.6M | |
| Basic EPS (Cont. Ops) | -$20.20 | -$2.00 | -$98.24 | -$70.34 | -$28.14 | |
| Diluted EPS (Cont. Ops) | -$20.20 | -$2.80 | -$98.24 | -$70.34 | -$28.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$121.9M | $46.8M | -$179.8M | -$124.8M | -$81.1M | |
| EBIT | -$129.1M | $40.1M | -$187.7M | -$139.2M | -$94.2M | |
| Revenue (Reported) | $84.8M | $309.9M | $95M | $161.4M | $99.5M | |
| Operating Income (Reported) | -$126.6M | $43.6M | -$199M | -$138.2M | -$104.9M | |
| Operating Income (Adjusted) | -$129.1M | $40.1M | -$187.7M | -$139.2M | -$94.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.7M | $25.9M | $22.9M | $28M | $24.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $37.8M | $43M | $59.4M | $44M | $21.7M | |
| Gross Profit | -$26.1M | -$17M | -$36.5M | -$16M | $2.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.4M | $19M | $18.2M | $16.9M | $15.7M | |
| Other Inc / (Exp) | $3.9M | $592K | $446K | -$1.1M | -$264K | |
| Operating Expenses | $16.4M | $19M | $18.2M | $16.9M | $15.7M | |
| Operating Income | -$42.4M | -$36M | -$54.7M | -$32.9M | -$13.3M | |
| Net Interest Expenses | $15.9M | $15.2M | $16.6M | $29.5M | $12.8M | |
| EBT. Incl. Unusual Items | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Minority Interest in Earnings | $726K | $2.3M | $2.6M | $1.6M | $1.1M | |
| Net Income to Common Excl Extra Items | -$53.7M | -$48.3M | -$68.3M | -$61.9M | -$25.3M | |
| Basic EPS (Cont. Ops) | -$5.40 | -$3.80 | -$86.20 | -$60.80 | -$20.60 | |
| Diluted EPS (Cont. Ops) | -$5.40 | -$3.80 | -$86.20 | -$60.80 | -$20.60 | |
| Weighted Average Basic Share | $10M | $12.9M | $792.8K | $1M | $1.2M | |
| Weighted Average Diluted Share | $10M | $12.9M | $792.8K | $1M | $1.2M | |
| EBITDA | -$36.8M | -$33.7M | -$51.7M | -$30.6M | -$10.4M | |
| EBIT | -$38.5M | -$35.4M | -$54.3M | -$34M | -$13.6M | |
| Revenue (Reported) | $11.7M | $25.9M | $22.9M | $28M | $24.1M | |
| Operating Income (Reported) | -$42.4M | -$36M | -$54.7M | -$32.9M | -$13.3M | |
| Operating Income (Adjusted) | -$38.5M | -$35.4M | -$54.3M | -$34M | -$13.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $99.9M | $291.9M | $178.7M | $76.1M | $40.4M | |
| Short Term Investments | -- | $15M | $14.7M | -- | -- | |
| Accounts Receivable, Net | $1.2M | $1.5M | $2.7M | $25.8M | $407K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.7M | $20.4M | $13.8M | $8.1M | $2.3M | |
| Other Current Assets | $2M | $3.2M | $3.2M | $2.4M | $2.4M | |
| Total Current Assets | $113.8M | $332M | $213.1M | $112.4M | $45.6M | |
| Property Plant And Equipment | $60.3M | $91.1M | $164.3M | $163M | $147.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $25.5M | $24.9M | $25.5M | $24.7M | $24.1M | |
| Other Intangibles | $10.9M | $8.5M | $6.2M | $4.4M | $3.4M | |
| Other Long-Term Assets | $4.1M | $9.5M | $4.5M | $9.3M | $5.8M | |
| Total Assets | $214.5M | $466M | $413.6M | $313.9M | $226.3M | |
| Accounts Payable | $17M | $30.5M | $40.9M | $61.4M | $61.5M | |
| Accrued Expenses | $23M | $35M | $31.7M | $40M | $28.2M | |
| Current Portion Of Long-Term Debt | $687K | $582K | $429K | -- | $2.6M | |
| Current Portion Of Capital Lease Obligations | $2M | $2.6M | $1.9M | $13M | $7.1M | |
| Other Current Liabilities | $69.9M | $75.7M | $101.5M | $141.2M | $121.9M | |
| Total Current Liabilities | $129.9M | $156.9M | $189M | $255.9M | $221.4M | |
| Long-Term Debt | $18.9M | $12.8M | $12.6M | $12.8M | $30.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $426M | $418M | $468.5M | $462.3M | $532.7M | |
| Common Stock | $2M | $2.6M | $3.1M | $197K | $236K | |
| Other Common Equity Adj | -- | $1.5M | $915K | -$955K | -$1.4M | |
| Common Equity | -$203.7M | $34.4M | -$61.3M | -$160.3M | -$326.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$7.8M | $13.5M | $6.4M | $11.9M | $20M | |
| Total Equity | -$211.5M | $47.9M | -$54.9M | -$148.4M | -$306.4M | |
| Total Liabilities and Equity | $214.5M | $466M | $413.6M | $313.9M | $226.3M | |
| Cash and Short Terms | $99.9M | $306.9M | $193.4M | $76.1M | $40.4M | |
| Total Debt | $19.7M | $13.6M | $13.2M | $12.9M | $33.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $119.4M | $247.7M | $164.8M | $52.9M | $18.5M | |
| Short Term Investments | -- | $15M | $24.4M | -- | -- | |
| Accounts Receivable, Net | $2.2M | $1.3M | $1.4M | $476K | $354K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $10.7M | $21.7M | $11.1M | $3.9M | $1.9M | |
| Other Current Assets | $3.4M | $4.8M | $3.9M | $3.1M | $2.4M | |
| Total Current Assets | $135.7M | $290.5M | $205.7M | $60.4M | $23.1M | |
| Property Plant And Equipment | $60.7M | $105.9M | $171.5M | $159.7M | $144.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $24.3M | $24.6M | $25.6M | $24.7M | $24.1M | |
| Other Intangibles | $10M | $7.8M | $5.7M | $4.2M | $3.3M | |
| Other Long-Term Assets | $4.2M | $12.5M | $4.4M | $7.6M | $5.6M | |
| Total Assets | $234.9M | $441.3M | $412.9M | $256.6M | $200.2M | |
| Accounts Payable | $19.5M | $34.5M | $46.8M | $50.7M | $64.2M | |
| Accrued Expenses | $26.2M | $28M | $28.4M | $36.3M | $29.6M | |
| Current Portion Of Long-Term Debt | $1.3M | $14M | $876K | $13.6M | $585K | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.7M | $11.2M | $13.5M | $4.5M | |
| Other Current Liabilities | $66.4M | $70.1M | $93.6M | $141.9M | $109.3M | |
| Total Current Liabilities | $138.4M | $163.1M | $190.9M | $256M | $208.3M | |
| Long-Term Debt | $18.9M | -- | $12.6M | -- | $32.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $432.9M | $413.7M | $466M | $446.9M | $522.6M | |
| Common Stock | $2.2M | $2.7M | $3.4M | $210K | $266K | |
| Other Common Equity Adj | -- | -- | $917K | -$1.1M | -$1.5M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$8.3M | $11.9M | $5.4M | $11.1M | $19.5M | |
| Total Equity | -$197.9M | $27.7M | -$53.1M | -$190.3M | -$322.4M | |
| Total Liabilities and Equity | $234.9M | $441.3M | $412.9M | $256.6M | $200.2M | |
| Cash and Short Terms | $119.4M | $262.7M | $189.2M | $52.9M | $18.5M | |
| Total Debt | $20.4M | $14.2M | $13.6M | $13.6M | $33.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$182.9M | -$28.7M | -$230.7M | -$257.4M | -$232.3M | |
| Depreciation & Amoritzation | $7.2M | $6.8M | $6.9M | $13.6M | $13.3M | |
| Stock-Based Compensation | $10.4M | $19.6M | $18.3M | $22.9M | $17.4M | |
| Change in Accounts Receivable | $16.2M | -$394K | $122K | -$23.5M | $25.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$139.1M | $10.1M | -$175.4M | -$224.2M | -$158.3M | |
| Capital Expenditures | $3.5M | $33.8M | $53.1M | $10M | $576K | |
| Cash Acquisitions | -$975K | -- | -$2.9M | -- | -- | |
| Cash From Investing | -$4.4M | -$43.2M | -$33.6M | $3.4M | $27K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.2M | -- | -- | -- | $20M | |
| Long-Term Debt Repaid | -$3.2M | -$1.3M | -$490K | -$8.9M | -$10.5M | |
| Repurchase of Common Stock | -- | -$1.7M | -$3.8M | -$5.2M | -- | |
| Other Financing Activities | -- | -$1.5M | -- | -- | $73.9M | |
| Cash From Financing | $183.9M | $225.3M | $95.8M | $119.9M | $122.8M | |
| Beginning Cash (CF) | $61.8M | $102.5M | $294.6M | $181.3M | $79.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $40.3M | $192.3M | -$113.2M | -$100.9M | -$35.4M | |
| Ending Cash (CF) | $102.5M | $294.6M | $181.3M | $79.8M | $44.1M | |
| Levered Free Cash Flow | -$142.6M | -$23.7M | -$228.4M | -$234.2M | -$158.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Depreciation & Amoritzation | $1.7M | $1.7M | $2.6M | $3.4M | $3.2M | |
| Stock-Based Compensation | $4M | $5M | $5.5M | $4.2M | $3.5M | |
| Change in Accounts Receivable | -$1M | $135K | $1.3M | $25.3M | $108K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$42.7M | -$52.4M | -$58.5M | -$38.2M | -$25.6M | |
| Capital Expenditures | $196K | $4.5M | $1.8M | $35K | $5K | |
| Cash Acquisitions | -- | -$3M | -- | -- | -- | |
| Cash From Investing | -$196K | -$7.5M | -$11.5M | $229K | $57K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $2.5M | |
| Long-Term Debt Repaid | -$423K | -$132K | -$1.9M | -$2.5M | -$5.3M | |
| Repurchase of Common Stock | -- | -$3.4M | -$2.8M | -- | -$22K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $63M | $16M | $56.3M | $14.8M | $3.6M | |
| Beginning Cash (CF) | $102.5M | $294.6M | $181.3M | $79.8M | $44.1M | |
| Foreign Exchange Rate Adjustment | -$492K | -$336K | -$90K | -$122K | $18K | |
| Additions / Reductions | $20M | -$43.9M | -$13.8M | -$23.1M | -$22M | |
| Ending Cash (CF) | $122M | $250.4M | $167.5M | $56.5M | $22.1M | |
| Levered Free Cash Flow | -$42.9M | -$56.9M | -$60.4M | -$38.2M | -$25.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$192M | -$24.9M | -$250.9M | -$250M | -$195.2M | |
| Depreciation & Amoritzation | $7.2M | $6.7M | $7.8M | $14.4M | $13.2M | |
| Stock-Based Compensation | $12M | $20.6M | $18.8M | $21.5M | $16.7M | |
| Change in Accounts Receivable | $1.5M | $780K | $1.3M | $589K | $111K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$147.3M | $498K | -$181.5M | -$203.9M | -$145.7M | |
| Capital Expenditures | $3M | $38.2M | $50.4M | $8.1M | $546K | |
| Cash Acquisitions | -$975K | -$3M | $85K | -- | -- | |
| Cash From Investing | -$4M | -$50.5M | -$37.6M | $15.1M | -$145K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.9M | -$1M | -$2.2M | -$9.6M | -$13.2M | |
| Repurchase of Common Stock | -- | -$5M | -$3.2M | -$2.4M | -$22K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $181.2M | $178.3M | $136M | $78.4M | $111.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $29.9M | $128.4M | -$83M | -$110.3M | -$34.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$150.4M | -$37.7M | -$231.9M | -$212M | -$146.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$54.4M | -$50.6M | -$70.9M | -$63.5M | -$26.4M | |
| Depreciation & Amoritzation | $1.7M | $1.7M | $2.6M | $3.4M | $3.2M | |
| Stock-Based Compensation | $4M | $5M | $5.5M | $4.2M | $3.5M | |
| Change in Accounts Receivable | -$1M | $135K | $1.3M | $25.3M | $108K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$42.7M | -$52.4M | -$58.5M | -$38.2M | -$25.6M | |
| Capital Expenditures | $196K | $4.5M | $1.8M | $35K | $5K | |
| Cash Acquisitions | -- | -$3M | -- | -- | -- | |
| Cash From Investing | -$196K | -$7.5M | -$11.5M | $229K | $57K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $2.5M | |
| Long-Term Debt Repaid | -$423K | -$132K | -$1.9M | -$2.5M | -$5.3M | |
| Repurchase of Common Stock | -- | -$3.4M | -$2.8M | -- | -$22K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $63M | $16M | $56.3M | $14.8M | $3.6M | |
| Beginning Cash (CF) | $102.5M | $294.6M | $181.3M | $79.8M | $44.1M | |
| Foreign Exchange Rate Adjustment | -$492K | -$336K | -$90K | -$122K | $18K | |
| Additions / Reductions | $20M | -$43.9M | -$13.8M | -$23.1M | -$22M | |
| Ending Cash (CF) | $122M | $250.4M | $167.5M | $56.5M | $22.1M | |
| Levered Free Cash Flow | -$42.9M | -$56.9M | -$60.4M | -$38.2M | -$25.6M | |
Get AGEN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGEN
Sector
P/E ratio
--
24.07x
PEG ratio
0.00x
0.00x
P/B ratio
--
1.81x
Price / LTM sales
1.13x
1.67x
Growth Metrics
AGEN
Sector
Revenue growth
-14.07%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
-7.17%
8.01%
Earnings forecast
$1.35
-$0.20
Profitability
AGEN
Sector
Profitability FY 2024
-$52.6M
$47.5M
Return on invested capital
--
-16.26%
Return on assets
-78.5%
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
11
Balance Sheet
AGEN
Sector
Total cash
$18.5M
$35.7M
Short term investments
--
$29.7M
Total assets
$226.3M
$106.9M
Long term debt
$33.6M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
